Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 676 to 690 of 1559 results for do not do recommendations

  1. What is the clinical and cost effectiveness of opioids for the management of acute sciatica?

    Recommendation ID NG59/8 Question What is the clinical and cost effectiveness of opioids for the management of acute sciatica?

    Research recommendation
    Published
    22 January 2021

  2. What is the clinical and cost effectiveness of antidepressants for the management of sciatica?

    Recommendation ID NG59/6 Question What is the clinical and cost effectiveness of antidepressants for the management of sciatica?

    Research recommendation
    Published
    26 October 2020

  3. Familial hypercholesterolaemia: identification and management (CG71)

    This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.

    Clinical guideline
    Last updated
    4 October 2019
    View recommendations

    Sections for CG71

  4. Single-step scaffold insertion for repairing symptomatic chondral knee defects (HTG728)

    Evidence-based recommendations on single-step scaffold insertion for repairing symptomatic chondral knee defects. This involves inserting a scaffold into the damaged area of the knee to support regrowth and repair of the cartilage.

    HealthTech guidance
    Last updated
    5 August 2025
    View recommendations

    Sections for HTG728

  5. Digital technologies to support self-management of COPD: early value assessment (HTG736)

    Early value assessment (EVA) guidance on digital technologies to support self-management of COPD.

    HealthTech guidance
    Last updated
    3 February 2026
    View recommendations

    Sections for HTG736

  6. Pembrolizumab with axitinib for untreated advanced renal cell carcinoma (TA650)

    Evidence-based recommendations on pembrolizumab (Keytruda) with axitinib (Inlyta) for untreated advanced renal cell carcinoma in adults.

    Technology appraisal guidance
    Published
    30 September 2020
    View recommendations

    Sections for TA650

  7. Breastfeeding support for parents with twins or triplets: What support with breastfeeding do parents of twins or triplets find helpful?

    Recommendation ID NG194/5 Question Breastfeeding support for parents with twins or triplets: What support with breastfeeding...

    Research recommendation
    Published
    6 August 2021

  8. CaRi-Heart for predicting cardiac risk in adults with suspected coronary artery disease (CAD)

    In development Reference number: GID-HTE10085 Expected publication date: TBC

    Health technology evaluations
    In development

  9. Do primary care practitioners use NICE guidance when encouraging people to be physically active?

    Recommendation ID PH44/6 Question Do primary care practitioners use NICE guidance when encouraging people to be physically...

    Research recommendation
    Published
    9 June 2015

  10. Total distal radioulnar joint replacement for symptomatic joint instability or arthritis (HTG451)

    Evidence-based recommendations on total distal radioulnar joint replacement for symptomatic joint instability or arthritis in adults. This involves removing the wrist end of the ulna and replacing it with a metal prosthesis that also attaches to the wrist end of the radius.

    HealthTech guidance
    Published
    8 November 2017
    View recommendations

    Sections for HTG451

  11. Grenz rays therapy for inflammatory skin conditions (HTG151)

    Evidence-based recommendations on Grenz rays therapy for inflammatory skin conditions. This involves exposing the skin to low-energy, non-penetrative electromagnetic radiation.

    HealthTech guidance
    Published
    28 November 2007
    View recommendations

    Sections for HTG151

  12. Lenvatinib with everolimus for previously treated advanced renal cell carcinoma (TA498)

    Evidence-based recommendations on lenvatinib (Kisplyx) with everolimus for previously treated advanced renal cell carcinoma in adults.

    Technology appraisal guidance
    Published
    24 January 2018
    View recommendations

    Sections for TA498

  13. How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Recommendation ID PH43/9 Question How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the...

    Research recommendation
    Published
    9 June 2015

  14. How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Recommendation ID PH43/10 Question How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the...

    Research recommendation
    Published
    9 June 2015

  15. Follow-up care after bariatric surgery: Do post-operative lifestyle intervention programmes (exercise, behavioural or dietary) improve weight loss and weight-loss maintenance following bariatric surgery?

    Recommendation ID CG189/03 Question Follow-up care after bariatric surgery: Do post-operative lifestyle intervention...

    Research recommendation
    Published
    30 September 2022